Psilocybin Assisted Therapy for Existential Distress in Cancer Patients by Jeff Guss, MD
This course covers psilocybin-assisted therapy for existential distress in cancer patients, including the study rationale, participant selection, preparation, dosing-session support, and integration. It also discusses the historical and cultural context of psychedelics and the role of the therapist in supporting inner-
Provider
Details
Enrollment
Course Overview
This course examines psilocybin-assisted therapy for existential distress in cancer patients. It explains how the study was shaped by the concept of existential distress, including how participants were selected, how preparation was structured, and how integration was approached after the dosing session. The content also reviews the broader history of psychedelics in culture, including their long-standing use in indigenous and religious contexts. It presents existential distress as a response to cancer diagnosis marked by fear, sadness, loss of meaning, and questioning of life’s purpose. The course describes the therapist’s role as supportive and minimally directive during the session, with emphasis on helping participants remain with their inner experience. It also addresses post-session integration and the relevance of transpersonal psychology in spiritual and existential work.
Who is this for?
Clinicians, therapists, and mental health professionals interested in psychedelic-assisted therapy, cancer-related existential distress, and integration work.
About the Provider
Educational platform co-founded by Dr. Will Van Derveer and Keith Kurlander that trains therapists, physicians, and nurses in psychedelic-assisted therapy through a year-long online program taught by 50+ experts including Robin Carhart-Harris, Michael Pollan, and Rick Doblin. IPI's curriculum covers evidence-based protocols for PTSD, depression, and anxiety, and partners with the Usona Institute and MAPS to prepare clinicians for emerging MDMA- and psilocybin-assisted treatments.
View IPI profileCourse Details
- PricePrice on request
- Lifecycle statusDiscontinued
- SkillsIntegrationPsilocybin TherapyUnderstanding existential distress in cancer careExplaining psilocybin-assisted therapy structureSupporting minimally directed psychedelic sessionsFacilitating post-session integrationInterpreting cultural and historical context of psychedelicsRecognizing the role of transpersonal psychologyUnderstanding psilocybin-assisted therapy in cancer careRecognizing existential distress in patients with cancerParticipant selection and preparationSupporting minimally directive dosing-session workApplying transpersonal psychology conceptsRecognizing existential distress in cancer patients
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jun 1, 2026
Accredited vs Non-Accredited Psychedelic Training
By AAA Learning Institute
Compare accredited and non-accredited psychedelic training programs, with an overview of what accreditation means and how to evaluate program quality. The page focuses on structure, practicum, curriculum, and practical considerations for prospective psilocybin facilitator students.
Aotearoa New Zealand Psilocybin Training
By Therapsil
A 106-hour live online training in psilocybin-assisted psychotherapy with an Aotearoa New Zealand-specific curriculum, delivered in partnership with PsyTrain. It is designed to support clinical practice with supervised learning and expert faculty input.
Dates not announced